KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Coterra Energy (CTRA) Research & Development (2016 - 2025)

Coterra Energy has reported Research & Development over the past 17 years, most recently at $6.0 million for Q4 2025.

  • Quarterly Research & Development changed 0.0% to $6.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.0 million through Dec 2025, up 8.0% year-over-year, with the annual reading at $27.0 million for FY2025, 8.0% up from the prior year.
  • Research & Development was $6.0 million for Q4 2025 at Coterra Energy, down from $7.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $10.0 million in Q3 2022 and troughed at $2.0 million in Q2 2021.
  • The 5-year median for Research & Development is $6.0 million (2022), against an average of $5.9 million.
  • Biggest five-year swings in Research & Development: tumbled 56.32% in 2021 and later surged 250.0% in 2022.
  • Tracing CTRA's Research & Development over 5 years: stood at $9.0 million in 2021, then plummeted by 33.33% to $6.0 million in 2022, then changed by 0.0% to $6.0 million in 2023, then changed by 0.0% to $6.0 million in 2024, then changed by 0.0% to $6.0 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $6.0 million, $7.0 million, and $4.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.